Literature DB >> 18612783

Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma.

Tadahiro Nozoe1, Emiko Mori, Ikuo Takahashi, Takahiro Ezaki.   

Abstract

PURPOSE: The preoperative elevation of serum C-reactive protein (CRP) is thought to be a prognosticator of carcinomas of the digestive tract. We conducted this study to investigate the clinical importance of the preoperative elevation of serum CRP in patients with colorectal carcinoma (CRC).
METHODS: We investigated the correlation between an elevated preoperative serum CRP level and the clinicopathologic factors, including prognosis, of 116 patients who underwent resection of CRC.
RESULTS: Forty-seven (40.5%) patients had an elevated serum CRP value preoperatively (group H) and 69 (59.5%) did not (group L). There were significant differences in the tumor size, proportion of poorly differentiated tumors, depth of invasion, lymph node metastasis, lymphatic invasion, and tumor stage between the two groups. Survival was significantly lower in group H than in group L (P < 0.0001). Multivariate analysis showed that the preoperative elevation of serum CRP (P = 0.0007), as well as poor differentiation (P = 0.027) and advanced tumor stage (P = 0.007) were independent prognostic factors in patients with CRC.
CONCLUSION: We found the preoperative elevation of serum CRP to be an independent prognostic indicator of CRC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612783     DOI: 10.1007/s00595-007-3680-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  27 in total

1.  Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.

Authors:  Tadahiro Nozoe; Masayuki Honda; Sadaaki Inutsuka; Mitshuhiro Yasuda; Daisuke Korenaga
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

2.  Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery.

Authors:  Gennaro Galizia; Michele Orditura; Ciro Romano; Eva Lieto; Paolo Castellano; Luigi Pelosio; Vincenzo Imperatore; Giuseppe Catalano; Carlo Pignatelli; Ferdinando De Vita
Journal:  Clin Immunol       Date:  2002-02       Impact factor: 3.969

3.  General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum.

Authors: 
Journal:  Jpn J Surg       Date:  1983-11

4.  Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma.

Authors:  T Nozoe; H Saeki; K Sugimachi
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

5.  Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.

Authors:  H J Nielsen; I J Christensen; S Sørensen; F Moesgaard; N Brünner
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

6.  Clinicopathological characteristics of mucinous carcinoma of the colon and rectum.

Authors:  T Nozoe; H Anai; S Nasu; K Sugimachi
Journal:  J Surg Oncol       Date:  2000-10       Impact factor: 3.454

7.  Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma.

Authors:  M Oka; K Yamamoto; M Takahashi; M Hakozaki; T Abe; N Iizuka; S Hazama; K Hirazawa; H Hayashi; A Tangoku; K Hirose; T Ishihara; T Suzuki
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

8.  Systemic inflammatory response predicts survival following curative resection of colorectal cancer.

Authors:  D C McMillan; K Canna; C S McArdle
Journal:  Br J Surg       Date:  2003-02       Impact factor: 6.939

9.  Effects of C-reactive protein on human lymphocyte responsiveness.

Authors:  M L Vetter; H Gewurz; B Hansen; K James; L L Baum
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

10.  Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.

Authors:  Shu Zheng; Ming-Yong Han; Zuo-Xiang Xiao; Jia-Ping Peng; Qi Dong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

View more
  20 in total

1.  Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.

Authors:  Tadahiro Nozoe; Rumi Matono; Hideki Ijichi; Takefumi Ohga; Takahiro Ezaki
Journal:  Int Surg       Date:  2014 Sep-Oct

2.  Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer.

Authors:  Yusuke Nakayama; Naoto Gotohda; Hidehito Shibasaki; Shogo Nomura; Takahiro Kinoshita; Ryuichi Hayashi
Journal:  Surg Today       Date:  2014-05-16       Impact factor: 2.549

3.  High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer.

Authors:  Judit Kocsis; Tamás Mészáros; Balázs Madaras; Eva Katalin Tóth; Szilárd Kamondi; Péter Gál; Lilian Varga; Zoltán Prohászka; George Füst
Journal:  Cell Stress Chaperones       Date:  2010-08-22       Impact factor: 3.667

4.  Elective palliative resection of incurable stage IV colorectal cancer: who really benefits from it?

Authors:  Renato Costi; Davide Di Mauro; Licia Veronesi; Andrea Ardizzoni; Pierfranco Salcuni; Luigi Roncoroni; Leopoldo Sarli; Vincenzo Violi
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

5.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer.

Authors:  Tadahiro Nozoe; Tomohiro Iguchi; Eisuke Adachi; Akito Matsukuma; Takahiro Ezaki
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

6.  C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin.

Authors:  Marcel C G van de Poll; Yvonne L B Klaver; Valery E P P Lemmens; Bart J M Leenders; Simon W Nienhuijs; Ignace H J T de Hingh
Journal:  Int J Colorectal Dis       Date:  2011-04-08       Impact factor: 2.571

7.  Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Eiji Noda; Hiroshi Ohtani; Yukio Nishiguchi; Kosei Hirakawa
Journal:  Surg Today       Date:  2014-05-10       Impact factor: 2.549

8.  Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery.

Authors:  Anna Pozza; Bruno Pauletti; Marco Scarpa; Cesare Ruffolo; Nicolò Bassi; Marco Massani
Journal:  Int J Colorectal Dis       Date:  2019-09-13       Impact factor: 2.571

9.  New prognostic score for the survival of patients with esophageal squamous cell carcinoma.

Authors:  Masaki Nakamura; Makoto Iwahashi; Mikihito Nakamori; Toshiyasu Ojima; Masahiro Katsuda; Takeshi Iida; Keiji Hayata; Tomoya Kato; Hiroki Yamaue
Journal:  Surg Today       Date:  2013-06-20       Impact factor: 2.549

10.  Five-point scoring system based on clinicopathological data: A convenient criterion to determine prognosis of patients with colorectal carcinoma.

Authors:  Tadahiro Nozoe; Mayuko Kohno; Tomohiro Iguchi; Takashi Maeda; Takahiro Ezaki
Journal:  Oncol Lett       Date:  2013-01-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.